Literature DB >> 19913146

Continuation rates and reasons for removal among Implanon users accessing two family planning clinics in Queensland, Australia.

Caroline Harvey1, Charrlotte Seib, Jayne Lucke.   

Abstract

BACKGROUND: This study examined demographic profile, continuation rates and reasons for removal among Implanon users accessing two family planning clinics in Queensland, Australia. STUDY
DESIGN: A retrospective chart audit of 976 women who attended for implant insertion over a 3-year period between May 2001 and May 2004.
RESULTS: Continuation rates showed that at 6 months after insertion, 94% of women continued, 74% continued at 1 year and 50% continued at 2 years. Metropolitan women were more likely than rural women to discontinue use because of dissatisfaction with bleeding patterns. Cox regression analysis showed that those attending the regional clinic experienced significantly shorter time to removal.
CONCLUSIONS: Implanon continuation rates and reasons for removal differ between clinics in metropolitan and rural locations. A cooling-off period did not affect the likelihood of continuation with Implanon. Preinsertion counselling should emphasize potential changes in bleeding patterns.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19913146     DOI: 10.1016/j.contraception.2009.05.132

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  21 in total

1.  Characteristics associated with discontinuation of long-acting reversible contraception within the first 6 months of use.

Authors:  Danielle S Grunloh; Teya Casner; Gina M Secura; Jeffrey F Peipert; Tessa Madden
Journal:  Obstet Gynecol       Date:  2013-12       Impact factor: 7.661

2.  Beyond the Surface: Care Seeking Among Patients Initiating Contraceptive Implant in an Urban Federally Qualified Health Center Network.

Authors:  Anita Ravi; Linda Prine; Gabrielle deFiebre; Susan E Rubin
Journal:  J Prim Care Community Health       Date:  2016-09-19

Review 3.  Contraceptive failure in the United States.

Authors:  James Trussell
Journal:  Contraception       Date:  2011-03-12       Impact factor: 3.375

4.  Etonogestrel contraceptive implant (Implanon): analysis of patient compliance and adverse effects in the breastfeeding period.

Authors:  Candan İltemir Duvan; Elif Gözdemir; Ikbal Kaygusuz; Zeynep Kamalak; Nilgün Öztürk Turhan
Journal:  J Turk Ger Gynecol Assoc       Date:  2010-09-01

5.  Incidence of Discontinuation of Long-Acting Reversible Contraception among Adolescent and Young Adult Women Served by an Urban Primary Care Clinic.

Authors:  Katharine K Sznajder; Kathy S Tomaszewski; Anne E Burke; Maria Trent
Journal:  J Pediatr Adolesc Gynecol       Date:  2016-07-14       Impact factor: 1.814

6.  Discontinuation of Reversible Long-Acting Contraceptive and Associated Factors among Female Users in Health Facilities of Hawassa City, Southern Ethiopia: Cross-Sectional Study.

Authors:  Belay Amare Abebe; Nega Assefa; Bezatu Mengistie
Journal:  Open Access J Contracept       Date:  2020-08-26

7.  Early Implanon Discontinuation and Associated Factors among Implanon User Women in Debre Tabor Town, Public Health Facilities, Northwest Ethiopia, 2016.

Authors:  Mengstu Melkamu Asaye; Tewodros Syoum Nigussie; Worku Mequannt Ambaw
Journal:  Int J Reprod Med       Date:  2018-01-21

8.  Determinant of Implanon Discontinuation among Women Who Ever Used Implanon in Diguna Fango District, Wolayita Zone, Southern Ethiopia: A Community Based Case Control Study.

Authors:  Amanuel Tadesse; Mekides Kondale; Eskzyiaw Agedew; Feleke Gebremeskel; Negussie Boti; Bilcha Oumer
Journal:  Int J Reprod Med       Date:  2017-11-06

9.  Sociodemographic profiles and use-dynamics of Jadelle (levonorgestrel) implants in Jos, Nigeria.

Authors:  V C Pam; J T Mutihir; D D Nyango; I Shambe; C O Egbodo; J A Karshima
Journal:  Niger Med J       Date:  2016 Nov-Dec

10.  Discontinuation rate of Implanon and its associated factors among women who ever used Implanon in Dale District, Southern Ethiopia.

Authors:  Abreham Nageso; Achamyelesh Gebretsadik
Journal:  BMC Womens Health       Date:  2018-11-20       Impact factor: 2.809

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.